Drug intelligence / Profile preview

Hydryal

Development stage: Unknown
Lead developer: Luminera Derm
Administration: Injection

Overview

Hydryal is an injectable aesthetic skin-booster product consisting of highly purified, non-animal, non-crosslinked hyaluronic acid gel used for mesotherapy and dermal hydration treatments. It is marketed as a transparent, homogeneous, biodegradable, latex‑free gel designed to enhance skin hydration, improve elasticity and texture, and provide a subtle volumizing effect by replenishing dermal hyaluronic acid stores.[8][11][13] Developed originally by Luminera and later acquired within the Allergan Aesthetics (AbbVie) dermal filler portfolio, Hydryal is positioned as a hydrating, soft-tissue injectable distinct from more structurally crosslinked volumizing fillers.[1][2][4][6][9]

Brand names: Hydryal

Beyond the preview

Go deeper on Hydryal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydryal.

Explore the full profile